Literature DB >> 14182561

ULCERATIVE COLITIS: DISEASE PATTERNS AND MEDICAL MANAGEMENT.

R W SHERBANIUK.   

Abstract

The extent of anatomical involvement (rectosigmoid, left colon, entire colon, segmental, and enterocolon) and clinical behaviour (acute fulminating, recurrent colitis, and chronic continuous colitis) must be considered in assessing the prognosis and management of patients with ulcerative colitis. The severity of symptoms and signs is highly variable. It ranges from the virtually asymptomatic patient with mild proctitis to the patient with acute fulminating colitis with arthritis, skin lesions and "toxic megacolon" who constitutes a medical emergency. Consequently, there is no single therapeutic formula to be applied in this disease. Treatment is reviewed with reference to the recent literature.

Entities:  

Keywords:  ADRENAL CORTEX HORMONES; CODEINE; COLITIS, ULCERATIVE; DRUG THERAPY; ENTEROCOLITIS, ACUTE; HEMORRHAGE, GASTROINTESTINAL; IATROGENIC DISEASE; INTESTINAL PERFORATION; PARENTERAL FEEDING; PENICILLIN G, PROCAINE; RADIOGRAPHY; RECTUM; STREPTOMYCIN; WATER-ELECTROLYTE BALANCE

Mesh:

Substances:

Year:  1964        PMID: 14182561      PMCID: PMC1927324     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  2 in total

Review 1.  The role of adipose stem cells in inflammatory bowel disease: From biology to novel therapeutic strategies.

Authors:  Francesco De Francesco; Maurizio Romano; Laura Zarantonello; Cesare Ruffolo; Daniele Neri; Nicolò Bassi; Antonio Giordano; Giacomo Zanus; Giuseppe A Ferraro; Umberto Cillo
Journal:  Cancer Biol Ther       Date:  2016-07-14       Impact factor: 4.742

Review 2.  Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological Treatments.

Authors:  Bruno Rafael Ramos de Mattos; Maellin Pereira Gracindo Garcia; Julia Bier Nogueira; Lisiery Negrini Paiatto; Cassia Galdino Albuquerque; Caique Lopes Souza; Luís Gustavo Romani Fernandes; Wirla Maria da Silva Cunha Tamashiro; Patricia Ucelli Simioni
Journal:  Mediators Inflamm       Date:  2015-08-03       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.